Home/Filings/4/0001638599-20-000919
4//SEC Filing

LaBelle Curt H 4

Accession 0001638599-20-000919

CIK 0001682639other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 4:24 PM ET

Size

13.7 KB

Accession

0001638599-20-000919

Insider Transaction Report

Form 4
Period: 2020-11-20
LaBelle Curt H
Director10% Owner
Transactions
  • Other

    Common Stock, par value $.0001

    2020-11-20453,3330 total(indirect: By LLC)
Holdings
  • Common Stock, par value $.0001

    35,273
  • Common Stock, par value $.0001

    (indirect: By Private Medical Equity, Inc.)
    606,667
  • Stock Option (right to buy)

    Exercise: $3.11Exp: 2029-08-16Common Stock (45,256 underlying)
    45,256
  • Stock Option (right to buy)

    (indirect: By Private Medical Equity, Inc.)
    Exercise: $1.24From: 2015-03-23Exp: 2025-03-23Common Stock (140,000 underlying)
    140,000
  • Stock Option (right to buy)

    Exercise: $1.24From: 2015-03-02Exp: 2025-03-02Common Stock (40,000 underlying)
    40,000
  • Stock Option (right to buy)

    Exercise: $1.95Exp: 2027-07-07Common Stock (133,334 underlying)
    133,334
  • Stock Option (right to buy)

    Exercise: $3.43Exp: 2030-09-11Common Stock (9,820 underlying)
    9,820
Footnotes (5)
  • [F1]On November 20, 2020, PME Investor Services Eyenovia, LLC, of which the reporting person is a manager, distributed its holdings of the Issuer's common stock in-kind and on a pro rata basis to its members.
  • [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]The option became exercisable as to 3,704 shares on August 7, 2017 and becomes exercisable in equal 3,704 share amounts on each of the 35 one-month anniversaries thereafter.
  • [F4]One-third of the option became exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
  • [F5]The option becomes exercisable on the earlier of September 11, 2021 or the date of the Issuer's 2021 annual meeting at stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.

Issuer

EYENOVIA, INC.

CIK 0001682639

Entity typeother

Related Parties

1
  • filerCIK 0001396235

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:24 PM ET
Size
13.7 KB